Leon Fouche

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 662 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

Essack Mitha, H. Ralph Schumacher, Leon Fouche et al. · Lara D. Veeken · 2013 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial

Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley et al. · The Lancet HIV · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson et al. · Scientific Reports · 2023 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14